Immune to Cancer: The CRI Blog
-
#AACR16 Update: The Promise of Synthetic Biology and CAR T Cell Technologies
Genetically engineered cells can be customized to target cancer.
-
#AACR16 Update: New Hope for Patients with Rare Skin Cancer, Head & Neck Cancer
Anti-PD-1 blockade and two other types of immunotherapy effective in treating multiple tumor types.
-
#AACR16 Update: The Cancer Research Institute’s Impact on Immunotherapy
Since our founding in 1953, the Cancer Research Institute has pioneered the field of cancer immunology, and… -
#AACR16 Update: How Immune Infiltration Predicts Survival in Cancer Patients
The Immunoscore is the strongest prognostic marker in colorectal cancer.
-
#AACR16 Update: Combination Therapies to Improve Anti-cancer Immune Responses
Complementary treatments can help overcome resistance to immunotherapy.
-
#AACR16 Update: Engaging the Immune System to Treat Pancreatic Cancer
Immunotherapy strategies to treat pancreatic cancer could also be effective in other difficult-to-treat cancers.
-
#AACR16 Update: Checkpoint Inhibition and Improving Anti-Tumor Immunity
Releasing the brakes on the immune system to overcome cancer
-
#AACR16 Update: Deciphering the Cancer Genome & Developing Tailored Treatments
To conquer cancer, scientists must first unmask its identity
-
Immunotherapy’s Bright Future
Tech entrepreneur Sean Parker bets big on immunotherapy.
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.